Category: Approval/Launch Region: North America · United States Company: Strides Pharma Science Ltd

Strides Pharmas Singapore Arm Gets Usfda Nod For Generic Version Of Oseltamivir Phosphate

Strides Pharmas Singapore Arm Gets Usfda Nod For Generic Version Of Oseltamivir Phosphate
The Product Is Bioequivalent And Therapeutically Equivalent To The Reference Listed Drug (Rld), Tamiflu For Oral Suspension, 6 Mg/Ml, Of Hoffmann-La Roche, Inc, It Added Strides Pharma Science Ltd On Monday Said Its Singapore-Based Arm Has Received Approval From The Us Health Regulator For Its Generic Version Of Oseltamivir Phosphate For Oral Suspension, Used For Treating Illness Due To Influenza. The Approval Granted By The Us Food & Drug Administration (Usfda) To Strides Pharma Global Pte. Ltd, Singapore, Is For Oseltamivir Phosphate For Oral Suspension Of Strength 6 Mg/Ml, The Company Said In A Statement Https://Health.Economictimes.Indiatimes.Com/News/Pharma/Strides-Pharmas-Singapore-Arm-Gets-Usfda-Nod-For-Generic-Version-Of-Oseltamivir-Phosphat

Found this useful? Share it with your team.

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!

Don't Have an Account? Sign Up!